West Pharmaceutical Services, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2007 | — | $490.9M | $108.4M |
| Dec 2008 | — | $487.1M | $87.2M |
| Jun 2009 | — | — | $84.3M |
| Sep 2009 | — | — | $79.5M |
| Dec 2009 | $379.1M | $579.1M | $83.1M |
| Mar 2010 | — | — | $65.9M |
| Jun 2010 | $356.8M | $641.5M | $67.5M |
| Sep 2010 | $369.3M | $632.1M | $97.1M |
| Dec 2010 | $358.1M | $625.7M | $110.2M |
| Mar 2011 | $364.7M | $663.1M | $94.6M |
| Jun 2011 | $367.2M | $696.0M | $110.4M |
| Sep 2011 | $323.3M | $691.3M | $161.9M |
| Dec 2011 | $299.3M | $654.9M | $91.8M |
| Mar 2012 | $294.9M | $694.7M | $100.2M |
| Jun 2012 | $296.4M | $679.5M | $107.0M |
| Sep 2012 | $362.1M | $717.1M | $143.2M |
| Dec 2012 | $378.8M | $728.9M | $161.9M |
| Mar 2013 | $428.4M | $745.9M | $175.0M |
| Jun 2013 | $394.7M | $784.2M | $190.6M |
| Sep 2013 | $381.1M | $836.7M | $221.7M |
| Dec 2013 | $371.3M | $906.4M | $230.0M |
| Mar 2014 | $390.7M | $934.6M | $230.0M |
| Jun 2014 | $359.3M | $972.6M | $226.7M |
| Sep 2014 | $315.5M | $970.1M | $246.8M |
| Dec 2014 | $308.3M | $956.9M | $255.3M |
| Mar 2015 | $231.9M | $941.1M | $207.1M |
| Jun 2015 | $231.7M | $989.4M | $252.0M |
| Sep 2015 | $231.5M | $995.3M | $256.8M |
| Dec 2015 | $228.9M | $1.02B | $274.6M |
| Mar 2016 | $229.5M | $1.07B | $178.1M |
| Jun 2016 | $228.9M | $1.11B | $202.7M |
| Sep 2016 | $228.6M | $1.14B | $205.9M |
| Dec 2016 | $226.2M | $1.12B | $203.0M |
| Mar 2017 | $194.2M | $1.17B | $169.4M |
| Jun 2017 | $195.7M | $1.24B | $226.6M |
| Sep 2017 | $196.6M | $1.32B | $269.3M |
| Dec 2017 | $197.0M | $1.28B | $235.9M |
| Mar 2018 | $198.0M | $1.31B | $199.8M |
| Jun 2018 | $196.4M | $1.28B | $225.5M |
| Sep 2018 | $196.2M | $1.35B | $297.3M |
| Dec 2018 | $196.0M | $1.40B | $337.4M |
| Mar 2019 | $195.5M | $1.37B | $265.5M |
| Jun 2019 | $196.0M | $1.45B | $326.7M |
| Sep 2019 | $195.1M | $1.49B | $396.0M |
| Dec 2019 | $255.0M | $1.57B | $439.1M |
| Mar 2020 | $254.4M | $1.49B | $335.3M |
| Jun 2020 | $253.9M | $1.61B | $445.9M |
| Sep 2020 | $253.4M | $1.72B | $519.4M |
| Dec 2020 | $252.9M | $1.85B | $615.5M |
| Mar 2021 | $252.3M | $1.83B | $483.7M |
| Jun 2021 | $251.8M | $2.03B | $576.2M |
| Sep 2021 | $209.9M | $2.20B | $688.0M |
| Dec 2021 | $208.8M | $2.34B | $762.6M |
| Mar 2022 | $208.3M | $2.33B | $667.7M |
| Jun 2022 | $207.8M | $2.42B | $718.5M |
| Sep 2022 | $207.2M | $2.47B | $729.0M |
| Dec 2022 | $206.7M | $2.68B | $894.3M |
| Mar 2023 | $206.1M | $2.78B | $886.3M |
| Jun 2023 | $205.6M | $2.75B | $796.3M |
| Sep 2023 | $152.1M | $2.87B | $898.6M |
| Dec 2023 | $72.8M | $2.88B | $853.9M |
| Mar 2024 | $72.8M | $2.68B | $601.8M |
| Jun 2024 | $72.9M | $2.58B | $446.2M |
| Sep 2024 | $202.6M | $2.75B | $490.9M |
| Dec 2024 | $202.6M | $2.68B | $484.6M |
| Mar 2025 | $202.6M | $2.68B | $404.2M |
| Jun 2025 | $202.6M | $2.93B | $509.7M |
| Sep 2025 | $202.7M | $3.05B | $628.5M |
| Dec 2025 | $202.8M | $3.18B | $791.3M |
| Mar 2026 | $202.8M | $2.99B | $521.4M |
| Jun 2026 | $202.9M | $2.99B | $435.8M |